Review decision date: December 2014
Following the recent surveillance review which checks the need to update CG95 Chest Pain, a partial update of this guideline will be scheduled into the work programme. Details of the update will be available on the guidelines in development webpage in due course. No further checks of this guideline will be scheduled until this update is published.
This guideline offers evidence-based advice on the care and support of adults with chest pain thought to be related to the heart. It covers the tests and treatment that should be offered to people while their condition is being diagnosed.
This guideline was previously called chest pain of recent onset: assessment and dianosis of recent onset chest pain or discomfort of suspected cardiac origin.
Recommendation 126.96.36.199 in this guideline replaces recommendation 1.1 of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction (TA73).
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.